SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-030346
Filing Date
2024-02-09
Accepted
2024-02-09 17:22:05
Documents
1
Group Members
COLUMN GROUP III GP, LPCOLUMN GROUP III-A, LPCOLUMN GROUP IV GP, LPCOLUMN GROUP IV, LPCOLUMN GROUP IV-A, LPCOLUMN GROUP, LLCPONOI CAPITAL II, LPPONOI CAPITAL, LPPONOI II MANAGEMENT, LLCPONOI MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d747658dsc13ga.htm SC 13G/A 159925
  Complete submission text file 0001193125-24-030346.txt   161876
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91387 | Film No.: 24616238
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP III, LP (Filed by) CIK: 0001668159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A